Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
MECAMYLAMINE HYDROCHLORIDE
(1956)
Small molecule
Neuronal acetylcholine receptor; alpha3/beta4 negative allosteric modulator
ORAL
Approved
Unknown
MECAMYLAMINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1956
UNII:
4956DJR58O
Molecule Type:
Small molecule
Molecular Formula:
C11H22ClN
Molecular Weight:
203.76
AlogP:
2.42
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
1.0
Source:
PROMAZINE
(1956)
Small molecule
Unknown
Unknown
Approved
Psychotic Disorders
PROMAZINE
×
Maximum Phase:
4
First Approval:
1956
UNII:
O9M39HTM5W
Molecule Type:
Small molecule
Molecular Formula:
C17H20N2S
Molecular Weight:
284.43
AlogP:
4.24
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
4.0
Source:
TETRACYCLINE PHOSPHATE COMPLEX
(1957)
Small molecule
Bacterial 70S ribosome inhibitor
ORAL
Approved
Unknown
TETRACYCLINE PHOSPHATE COMPLEX
×
Maximum Phase:
4
First Approval:
1957
UNII:
6B7BK5H33B
Molecule Type:
Small molecule
Molecular Formula:
C22H27N2O12P
Molecular Weight:
542.43
AlogP:
-0.21
PSA:
181.62
HBD:
6.0
HBA:
#RotB:
2.0
Source:
ISOPROPAMIDE IODIDE
(1957)
Small molecule
Muscarinic acetylcholine receptor M1 antagonist
ORAL
Approved
Unknown
ISOPROPAMIDE IODIDE
×
Maximum Phase:
4
First Approval:
1957
UNII:
E0KNA372SZ
Molecule Type:
Small molecule
Molecular Formula:
C23H33IN2O
Molecular Weight:
480.43
AlogP:
4.11
PSA:
43.09
HBD:
1.0
HBA:
#RotB:
8.0
Source:
PERPHENAZINE
(1957)
Small molecule
Dopamine D2 receptor antagonist
INJECTION; ORAL
Approved
Postoperative Nausea and Vomiting; Psychotic Disorders; Schizophrenia
PERPHENAZINE
×
Maximum Phase:
4
First Approval:
1957
UNII:
FTA7XXY4EZ
Molecule Type:
Small molecule
Molecular Formula:
C21H26ClN3OS
Molecular Weight:
403.98
AlogP:
3.94
PSA:
29.95
HBD:
1.0
HBA:
#RotB:
6.0
Source:
ISOPROPAMIDE
(1957)
Small molecule
Unknown
Unknown
Approved
Digestive System Diseases
ISOPROPAMIDE
×
Maximum Phase:
4
First Approval:
1957
UNII:
8B9I31H724
Molecule Type:
Small molecule
Molecular Formula:
C23H33N2O+
Molecular Weight:
353.53
AlogP:
4.11
PSA:
43.09
HBD:
1.0
HBA:
#RotB:
8.0
Source:
PROPOXYPHENE HYDROCHLORIDE
(1957)
Small molecule
Mu opioid receptor agonist
ORAL
Approved
Pain
PROPOXYPHENE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1957
UNII:
CB2TL9PS0T
Molecule Type:
Small molecule
Molecular Formula:
C22H30ClNO2
Molecular Weight:
375.94
AlogP:
4.28
PSA:
29.54
HBD:
0.0
HBA:
#RotB:
8.0
Source:
CHLORAMBUCIL
(1957)
Small molecule
DNA inhibitor
ORAL
Approved
Hodgkin Disease; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma
CHLORAMBUCIL
×
Maximum Phase:
4
First Approval:
1957
UNII:
18D0SL7309
Molecule Type:
Small molecule
Molecular Formula:
C14H19Cl2NO2
Molecular Weight:
304.22
AlogP:
3.38
PSA:
40.54
HBD:
1.0
HBA:
#RotB:
9.0
Source:
TRIFLUPROMAZINE
(1957)
Small molecule
Dopamine D2 receptor antagonist
ORAL
Approved
Psychotic Disorders
TRIFLUPROMAZINE
×
Maximum Phase:
4
First Approval:
1957
UNII:
RO16TQF95Y
Molecule Type:
Small molecule
Molecular Formula:
C18H19F3N2S
Molecular Weight:
352.43
AlogP:
5.26
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
4.0
Source:
NEOMYCIN
(1957)
Small molecule
Bacterial 70S ribosome inhibitor
Unknown
Investigational
Unknown
NEOMYCIN
×
Maximum Phase:
4
First Approval:
1957
UNII:
I16QD7X297
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
METHSUXIMIDE
(1957)
Small molecule
Voltage-gated T-type calcium channel blocker
ORAL
Approved
Epilepsy; Seizures
METHSUXIMIDE
×
Maximum Phase:
4
First Approval:
1957
UNII:
0G76K8X6C0
Molecule Type:
Small molecule
Molecular Formula:
C12H13NO2
Molecular Weight:
203.24
AlogP:
1.33
PSA:
37.38
HBD:
0.0
HBA:
#RotB:
1.0
Source:
POLYESTRADIOL PHOSPHATE
(1957)
Small molecule
Estrogen receptor alpha agonist
INJECTION
Approved
Unknown
POLYESTRADIOL PHOSPHATE
×
Maximum Phase:
4
First Approval:
1957
UNII:
P14877CDX2
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MECLIZINE
(1957)
Small molecule
Unknown
Unknown
Approved
Hypersensitivity
MECLIZINE
×
Maximum Phase:
4
First Approval:
1957
UNII:
3L5TQ84570
Molecule Type:
Small molecule
Molecular Formula:
C25H27ClN2
Molecular Weight:
390.96
AlogP:
5.56
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
5.0
Source:
BROMPHENIRAMINE MALEATE
(1957)
Small molecule
Histamine H1 receptor antagonist
INJECTION; ORAL
Approved
Common Cold; Cough; Hypersensitivity
BROMPHENIRAMINE MALEATE
×
Maximum Phase:
4
First Approval:
1957
UNII:
IXA7C9ZN03
Molecule Type:
Small molecule
Molecular Formula:
C20H23BrN2O4
Molecular Weight:
435.32
AlogP:
3.93
PSA:
16.13
HBD:
0.0
HBA:
#RotB:
5.0
Source:
ANISINDIONE
(1957)
Small molecule
Vitamin K-dependent gamma-carboxylase inhibitor
ORAL
Approved
Unknown
ANISINDIONE
×
Maximum Phase:
4
First Approval:
1957
UNII:
S747T1ERAJ
Molecule Type:
Small molecule
Molecular Formula:
C16H12O3
Molecular Weight:
252.27
AlogP:
2.86
PSA:
43.37
HBD:
0.0
HBA:
#RotB:
2.0
Source:
ORPHENADRINE HYDROCHLORIDE
(1957)
Small molecule
Glutamate [NMDA] receptor antagonist
ORAL
Approved
Parkinson Disease
ORPHENADRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1957
UNII:
UBY910DUXH
Molecule Type:
Small molecule
Molecular Formula:
C18H24ClNO
Molecular Weight:
305.85
AlogP:
3.66
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
6.0
Source:
SODIUM PHOSPHATE
(1957)
Small molecule
Saline laxative
Unknown
Approved
Constipation
SODIUM PHOSPHATE
×
Maximum Phase:
4
First Approval:
1957
UNII:
SE337SVY37
Molecule Type:
Small molecule
Molecular Formula:
HNa2O4P
Molecular Weight:
141.96
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PROCHLORPERAZINE EDISYLATE
(1957)
Small molecule
Dopamine D2 receptor antagonist
INJECTION; ORAL
Approved
Unknown
PROCHLORPERAZINE EDISYLATE
×
Maximum Phase:
4
First Approval:
1957
UNII:
PG20W5VQZS
Molecule Type:
Small molecule
Molecular Formula:
C22H30ClN3O6S3
Molecular Weight:
564.15
AlogP:
4.58
PSA:
9.72
HBD:
0.0
HBA:
#RotB:
4.0
Source:
ISOFLUROPHATE
(1957)
Small molecule
Acetylcholinesterase inhibitor
OPHTHALMIC
Approved
Glaucoma
ISOFLUROPHATE
×
Maximum Phase:
4
First Approval:
1957
UNII:
12UHW9R67N
Molecule Type:
Small molecule
Molecular Formula:
C6H14FO3P
Molecular Weight:
184.15
AlogP:
2.91
PSA:
35.53
HBD:
0.0
HBA:
#RotB:
4.0
Source:
CHLORPROMAZINE HYDROCHLORIDE
(1957)
Small molecule
D2-like dopamine receptor antagonist
INJECTION; ORAL
Approved
Unknown
CHLORPROMAZINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1957
UNII:
9WP59609J6
Molecule Type:
Small molecule
Molecular Formula:
C17H20Cl2N2S
Molecular Weight:
355.33
AlogP:
4.89
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
4.0
Source:
METHOCARBAMOL
(1957)
Small molecule
Carbonic anhydrase I inhibitor
IM-IV; INJECTION; ORAL
Approved
Unknown
METHOCARBAMOL
×
Maximum Phase:
4
First Approval:
1957
UNII:
125OD7737X
Molecule Type:
Small molecule
Molecular Formula:
C11H15NO5
Molecular Weight:
241.24
AlogP:
0.53
PSA:
91.01
HBD:
2.0
HBA:
#RotB:
6.0
Source:
SODIUM PHOSPHATE P 32
(1957)
Small molecule
Unknown
Unknown
Approved
Unknown
SODIUM PHOSPHATE P 32
×
Maximum Phase:
4
First Approval:
1957
UNII:
O181101B5G
Molecule Type:
Small molecule
Molecular Formula:
HNa2O4P
Molecular Weight:
142.96
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ETHOTOIN
(1957)
Small molecule
Sodium channel alpha subunit blocker
ORAL
Approved
Epilepsy; Seizures
ETHOTOIN
×
Maximum Phase:
4
First Approval:
1957
UNII:
46QG38NC4U
Molecule Type:
Small molecule
Molecular Formula:
C11H12N2O2
Molecular Weight:
204.23
AlogP:
1.3
PSA:
49.41
HBD:
1.0
HBA:
#RotB:
2.0
Source:
PROPOXYPHENE
(1957)
Small molecule
Unknown
Unknown
Approved
Pain
PROPOXYPHENE
×
Maximum Phase:
4
First Approval:
1957
UNII:
S2F83W92TK
Molecule Type:
Small molecule
Molecular Formula:
C22H29NO2
Molecular Weight:
339.48
AlogP:
4.28
PSA:
29.54
HBD:
0.0
HBA:
#RotB:
8.0
Source:
ORPHENADRINE
(1957)
Small molecule
Unknown
Unknown
Approved
Unknown
ORPHENADRINE
×
Maximum Phase:
4
First Approval:
1957
UNII:
AL805O9OG9
Molecule Type:
Small molecule
Molecular Formula:
C18H23NO
Molecular Weight:
269.39
AlogP:
3.66
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
6.0
Source:
PHENPROCOUMON
(1957)
Small molecule
Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor
ORAL
Approved
Thrombosis
PHENPROCOUMON
×
Maximum Phase:
4
First Approval:
1957
UNII:
Q08SIO485D
Molecule Type:
Small molecule
Molecular Formula:
C18H16O3
Molecular Weight:
280.32
AlogP:
4.04
PSA:
50.44
HBD:
1.0
HBA:
#RotB:
3.0
Source:
CHLORPROMAZINE
(1957)
Small molecule
D2-like dopamine receptor antagonist
RECTAL
Approved
Conduct Disorder; Porphyrias; Postoperative Nausea and Vomiting; Psychotic Disorders; Schizophrenia
CHLORPROMAZINE
×
Maximum Phase:
4
First Approval:
1957
UNII:
U42B7VYA4P
Molecule Type:
Small molecule
Molecular Formula:
C17H19ClN2S
Molecular Weight:
318.87
AlogP:
4.89
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
4.0
Source:
NEOMYCIN SULFATE
(1957)
Small molecule
Bacterial 70S ribosome inhibitor
FOR RX COMPOUNDING; ORAL
Approved
Unknown
NEOMYCIN SULFATE
×
Maximum Phase:
4
First Approval:
1957
UNII:
057Y626693
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRIAMCINOLONE
(1957)
Small molecule
Glucocorticoid receptor agonist
ORAL
Approved
Eye Diseases; Hemorrhoids; Lung Diseases, Obstructive; Nasal Obstruction; Skin Diseases
TRIAMCINOLONE
×
Maximum Phase:
4
First Approval:
1957
UNII:
1ZK20VI6TY
Molecule Type:
Small molecule
Molecular Formula:
C21H27FO6
Molecular Weight:
394.44
AlogP:
0.62
PSA:
115.06
HBD:
4.0
HBA:
#RotB:
2.0
Source:
BROMPHENIRAMINE
(1957)
Small molecule
Unknown
Unknown
Approved
Hypersensitivity
BROMPHENIRAMINE
×
Maximum Phase:
4
First Approval:
1957
UNII:
H57G17P2FN
Molecule Type:
Small molecule
Molecular Formula:
C16H19BrN2
Molecular Weight:
319.25
AlogP:
3.93
PSA:
16.13
HBD:
0.0
HBA:
#RotB:
5.0
Source:
TRIFLUPROMAZINE HYDROCHLORIDE
(1957)
Small molecule
Dopamine D2 receptor antagonist
INJECTION; ORAL
Approved
Unknown
TRIFLUPROMAZINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1957
UNII:
9E75N4A5HM
Molecule Type:
Small molecule
Molecular Formula:
C18H20ClF3N2S
Molecular Weight:
388.89
AlogP:
5.26
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
4.0
Source:
MECLIZINE HYDROCHLORIDE
(1957)
Small molecule
Histamine H1 receptor antagonist
ORAL
Approved
Motion Sickness; Nausea; Postoperative Nausea and Vomiting; Vertigo; Vomiting
MECLIZINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1957
UNII:
HDP7W44CIO
Molecule Type:
Small molecule
Molecular Formula:
C25H31Cl3N2O
Molecular Weight:
481.9
AlogP:
5.56
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
5.0
Source:
METHYLPREDNISOLONE
(1957)
Small molecule
Glucocorticoid receptor agonist
ORAL
Approved
Acne Vulgaris; Arthritis, Psoriatic; Arthritis, Rheumatoid; Asthma; Bursitis; Colitis, Ulcerative; Crohn Disease; Dermatitis, Atopic; Inflammation; Multiple Sclerosis; Osteoarthritis; Pneumonia; Tenosynovitis
METHYLPREDNISOLONE
×
Maximum Phase:
4
First Approval:
1957
UNII:
X4W7ZR7023
Molecule Type:
Small molecule
Molecular Formula:
C22H30O5
Molecular Weight:
374.48
AlogP:
1.8
PSA:
94.83
HBD:
3.0
HBA:
#RotB:
2.0
Source:
DESERPIDINE
(1957)
Small molecule
Synaptic vesicular amine transporter inhibitor
ORAL
Approved
Hypertension
DESERPIDINE
×
Maximum Phase:
4
First Approval:
1957
UNII:
9016E3VB47
Molecule Type:
Small molecule
Molecular Formula:
C32H38N2O8
Molecular Weight:
578.66
AlogP:
4.16
PSA:
108.55
HBD:
1.0
HBA:
#RotB:
7.0
Source:
CHLORPROPAMIDE
(1958)
Small molecule
Sulfonylurea receptor 1, Kir6.2 blocker
ORAL
Approved
Diabetes Mellitus; Diabetes Mellitus, Type 2
CHLORPROPAMIDE
×
Maximum Phase:
4
First Approval:
1958
UNII:
WTM2C3IL2X
Molecule Type:
Small molecule
Molecular Formula:
C10H13ClN2O3S
Molecular Weight:
276.75
AlogP:
1.74
PSA:
75.27
HBD:
2.0
HBA:
#RotB:
4.0
Source:
PHENYLPROPANOLAMINE
(1958)
Small molecule
Unknown
Unknown
Approved
Nasal Obstruction
PHENYLPROPANOLAMINE
×
Maximum Phase:
4
First Approval:
1958
UNII:
33RU150WUN
Molecule Type:
Small molecule
Molecular Formula:
C9H13NO
Molecular Weight:
151.21
AlogP:
1.07
PSA:
46.25
HBD:
2.0
HBA:
#RotB:
2.0
Source:
1
2
…
5
6
7
8
9
10
11
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA